<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1281445</PMID><DateCompleted><Year>1993</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0042-9686</ISSN><JournalIssue CitedMedium="Print"><Volume>70</Volume><Issue>5</Issue><PubDate><Year>1992</Year></PubDate></JournalIssue><Title>Bulletin of the World Health Organization</Title><ISOAbbreviation>Bull World Health Organ</ISOAbbreviation></Journal><ArticleTitle>Screening of cases of acute flaccid paralysis for poliomyelitis eradication: ways to improve specificity.</ArticleTitle><Pagination><StartPage>591</StartPage><EndPage>596</EndPage><MedlinePgn>591-6</MedlinePgn></Pagination><Abstract><AbstractText>The Pan American Health Organization in 1985 adopted an initiative to eradicate poliomyelitis from the Western Hemisphere. In 1990, over 2000 cases of acute flaccid paralysis (AFP) were reported in this region, of which &lt; 1% were determined to be caused by wild poliovirus. At present, the eradication programme uses AFP as the criterion for surveillance of children aged &lt; 15 years; this is 100% sensitive, but not specific. To minimize unnecessary diagnostic investigations, we studied all 4333 cases of AFP reported to the programme during 1989 and 1990 in order to develop more efficient operational screening criteria for cases of AFP. Among children with AFP, the use of criteria such as age &lt; 6 years and either presence of fever at the onset of paralysis or a &lt; 4-day period for complete development of paralysis resulted in a sensitivity of 96% (95% C.I. 90-103%) and specificity of 49% (C.I. 47-52%). With criteria of age &lt; 6 years and fever present at the onset of paralysis the sensitivity was 75% (C.I. 61-89%) and specificity was 73% (C.I. 71-75%). These results suggest that by screening young children with AFP who either had fever at the onset or showed a rapid progression of paralysis, the number of cases of AFP requiring investigation can be reduced by one half, with minimal compromise in the sensitivity of confirmed poliomyelitis case detection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andrus</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>EPI/PAHO, Expanded Programme on Immunization, Pan American Health Organization, Washington, DC 20037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Quadros</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Oliv&#xe9;</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Hull</LastName><ForeName>H F</ForeName><Initials>HF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Bull World Health Organ</MedlineTA><NlmUniqueID>7507052</NlmUniqueID><ISSNLinking>0042-9686</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000569" MajorTopicYN="N" Type="Geographic">Americas</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004812" MajorTopicYN="Y">Epidemiologic Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009123" MajorTopicYN="Y">Muscle Hypotonia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="PIP">080955</OtherID><OtherID Source="POP">00220956</OtherID><KeywordList Owner="PIP"><Keyword MajorTopicYN="Y">Age Factors</Keyword><Keyword MajorTopicYN="N">Biology</Keyword><Keyword MajorTopicYN="Y">Child</Keyword><Keyword MajorTopicYN="Y">Classification</Keyword><Keyword MajorTopicYN="N">Demographic Factors</Keyword><Keyword MajorTopicYN="N">Diseases</Keyword><Keyword MajorTopicYN="Y">Examinations And Diagnoses</Keyword><Keyword MajorTopicYN="N">International Agencies</Keyword><Keyword MajorTopicYN="Y">Neurologic Effects</Keyword><Keyword MajorTopicYN="N">Organizations</Keyword><Keyword MajorTopicYN="Y">Paho</Keyword><Keyword MajorTopicYN="N">Physiology</Keyword><Keyword MajorTopicYN="N">Population</Keyword><Keyword MajorTopicYN="N">Population Characteristics</Keyword><Keyword MajorTopicYN="N">Research Methodology</Keyword><Keyword MajorTopicYN="Y">Screening</Keyword><Keyword MajorTopicYN="Y">Signs And Symptoms</Keyword><Keyword MajorTopicYN="N">Un</Keyword><Keyword MajorTopicYN="Y">Viral Diseases</Keyword><Keyword MajorTopicYN="N">Who</Keyword><Keyword MajorTopicYN="N">Youth</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1992</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1281445</ArticleId><ArticleId IdType="pmc">PMC2393371</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pediatr Infect Dis J. 1991 Mar;10(3):222-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2041671</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 1989 Aug 11;38(31):532-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2547150</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 1990 Aug 24;39(33):557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">2116586</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>